a Clinica Malattie Infettive, IRCCS AOU San Martino-IST, Università di Genova , Genova , Italy.
Virulence. 2016 Apr 2;7(3):353-65. doi: 10.1080/21505594.2016.1140296. Epub 2016 Jan 13.
Bloodstream infections (BSI) carry a heavy burden of morbidity and mortality in modern internal medicine wards (IMW). These wards are often filled with elderly subjects with several risk factors for BSI, such as multiple comorbidities, polypharmacy, immunosuppression, and indwelling devices. Diagnosing BSI in such a setting might require a high degree of suspicion, since the clinical presentation could be affected by underlying conditions and concomitant medications, which might delay the administration of an appropriate antimicrobial therapy, an event strongly and unfavorably influencing survival. Furthermore, selecting the appropriate antimicrobial therapy to treat these patients is becoming an increasingly complex task in which all possible benefits and costs should be carefully analyzed from patient and public health perspectives. Only a specialized, continuous, and interdisciplinary approach could really improve the management of IMW patients in an era of increasing antimicrobial resistance and complexity of care.
血流感染(BSI)给现代内科病房(IMW)带来了沉重的发病和死亡负担。这些病房常常挤满了有多种 BSI 风险因素的老年患者,如多种合并症、多种药物治疗、免疫抑制和留置装置。在这种情况下诊断 BSI 可能需要高度怀疑,因为临床表现可能受到潜在疾病和伴随药物的影响,这可能会延迟给予适当的抗菌治疗,这种情况强烈且不利地影响生存。此外,选择适当的抗菌治疗来治疗这些患者的任务变得越来越复杂,从患者和公共卫生的角度来看,应仔细分析所有可能的获益和成本。只有专门的、持续的和跨学科的方法才能真正改善在抗菌药物耐药性不断增加和治疗复杂性不断增加的时代对 IMW 患者的管理。